JPX:4592
SanBio Company Limited · JPX · Healthcare · JPY · FY for 2026
Figures on this page computed 2026-11-08 12:49 UTC
Last close
n/aJPY
Market data
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- JPY
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
0.09Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- JPY
- computed
Price is the furthest below its sector's middle: 0.23 against 0.45 on the market's range.
- Growth-33.3%29 of 100, below its sector
- Returns on capital-28.2%23 of 100, above its sector
- Marginsn/anot placed
- Price4.3x23 of 100, below its sector
- Safety0.0989 of 100, above its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
3 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Salesn/a
Its own average over 4 years, 657.2M.
- Profit1.04x
Its own average over 10 years, -3.68B.
- Free cash flow0.84x
Its own average over 10 years, -4.55B.
- Debt0.58x
Its own average over 10 years, 2.14B.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 0.58 times.
Profit is 1.04 times its own 10-year average; Free cash flow is 0.84 times its own 10-year average; Debt is 0.58 times its own 10-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2026
Sales against its own 4-year averagen/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- JPY
Profit against its own 10-year average1.04
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- JPY
Free cash flow against its own 10-year average0.84
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- JPY
Debt against its own 10-year average0.58
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- JPY
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- JPY